Publicacions en què col·labora amb Rafael Cantón Moreno (33)

2024

  1. Bronchopulmonary colonization patterns in Spanish people with cystic fibrosis: Results of a national multicentre study

    Enfermedades Infecciosas y Microbiologia Clinica

2022

  1. The Human Mycobiome in Chronic Respiratory Diseases: Current Situation and Future Perspectives

    Microorganisms, Vol. 10, Núm. 4

2020

  1. Erratum to Spanish Guidelines on the Evaluation and Diagnosis of Bronchiectasis in Adults [Arch Bronconeumol. 2018;54(2):79–87] (Archivos de Bronconeumologia (2018) 54(2) (79–87), (S0300289617302727), (10.1016/j.arbres.2017.07.015))

    Archivos de Bronconeumologia

  2. Impact of pseudomonas aeruginosa infection on patients with chronic inflammatory airway diseases

    Journal of Clinical Medicine, Vol. 9, Núm. 12, pp. 1-32

  3. Long-term docosahexaenoic acid (DHA) supplementation in cystic fibrosis patients: a randomized, multi-center, double-blind, placebo-controlled trial

    Prostaglandins Leukotrienes and Essential Fatty Acids, Vol. 162

2018

  1. Fungi in bronchiectasis: A concise review

    International Journal of Molecular Sciences, Vol. 19, Núm. 1

  2. Spanish Guidelines on Treatment of Bronchiectasis in Adults

    Archivos de Bronconeumologia, Vol. 54, Núm. 2, pp. 88-98

  3. Spanish Guidelines on the Evaluation and Diagnosis of Bronchiectasis in Adults

    Archivos de Bronconeumologia, Vol. 54, Núm. 2, pp. 79-87

2017

  1. Antibiotic resistance and population structure of cystic fibrosis Pseudomonas aeruginosa isolates from a Spanish multi-centre study

    International Journal of Antimicrobial Agents, Vol. 50, Núm. 3, pp. 334-341

  2. Individual patterns of complexity in cystic fibrosis lung microbiota, including predator bacteria, over a 1-year period

    mBio, Vol. 8, Núm. 5

2016

  1. Bronchopulmonary infection-colonization patterns in Spanish cystic fibrosis patients: Results from a national multicenter study

    Journal of Cystic Fibrosis, Vol. 15, Núm. 3, pp. 357-365

  2. Emergence of cfr-mediated linezolid resistance in a methicillin-resistant Staphylococcus aureus epidemic clone isolated from patients with cystic fibrosis

    Antimicrobial Agents and Chemotherapy, Vol. 60, Núm. 3, pp. 1878-1882

2015

  1. In vivo attenuation and genetic evolution of a ST247-SCCmecI MRSA clone after 13 years of pathogenic bronchopulmonary colonization in a patient with cystic fibrosis: Implications of the innate immune response

    Mucosal Immunology, Vol. 8, Núm. 2, pp. 362-371

  2. Response to "In vivo attenuation and genetic evolution of a ST247-SCCmecI MRSA clone after 13 years of pathogenic bronchopulmonary colonization in a patient with cystic fibrosis: Implications of the innate immune response"

    Mucosal Immunology

  3. Spanish Consensus on the Prevention and Treatment of Pseudomonas aeruginosa Bronchial Infections in Cystic Fibrosis Patients

    Archivos de Bronconeumologia, Vol. 51, Núm. 3, pp. 140-150

2014

  1. Improvement of digestive health and reduction in proteobacterial populations in the gut microbiota of cystic fibrosis patients using a Lactobacillus reuteri probiotic preparation: A double blind prospective study

    Journal of Cystic Fibrosis, Vol. 13, Núm. 6, pp. 716-722

2013

  1. Inhaled antibiotics for the treatment of chronic bronchopulmonary Pseudomonas aeruginosa infection in cystic fibrosis: Systematic review of randomised controlled trials

    Expert Opinion on Pharmacotherapy, Vol. 14, Núm. 9, pp. 1135-1149

2012

  1. Clinical and microbiological features of a cystic fibrosis patient chronically colonized with Pandoraea sputorum identified by combining 16S rRNA sequencing and matrix-assisted laser desorption ionization - Time of flight mass spectrometry

    Journal of Clinical Microbiology, Vol. 50, Núm. 3, pp. 1096-1098

  2. Emergence of a mutL mutation causing multilocus sequence typing- pulsed-field gel electrophoresis discrepancy among Pseudomonas aeruginosa isolates from a cystic fibrosis patient

    Journal of Clinical Microbiology, Vol. 50, Núm. 5, pp. 1777-1778

  3. In vitro prevention of Pseudomonas aeruginosa early biofilm formation with antibiotics used in cystic fibrosis patients

    International Journal of Antimicrobial Agents, Vol. 40, Núm. 2, pp. 173-176